2025 annual financial data
Abeona Therapeutics 2025 Net margin
Direct answer
Net margin was 1,223.08%.
Operating income was -89,448,000 USD and net income was 71,183,000 USD.
Operating cash flow was -76,326,000 USD.
Get free Abeona Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,820,000 USD
- Operating income
- -89,448,000 USD
- Net income
- 71,183,000 USD
- Operating cash flow
- -76,326,000 USD